Trials / Sponsors / Kinevant Sciences GmbH
Kinevant Sciences GmbH
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis Sarcoidosis, Pulmonary | Phase 2 | 2022-08-31 |
| Terminated | A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarc Sarcoidosis, Cardiac | Phase 2 | 2022-08-23 |
| Completed | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Dist COVID-19 | Phase 2 | 2020-04-15 |
| Completed | Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis Inflammation, Rheumatic Diseases | Phase 1 | 2019-11-12 |